Acelyrin News

Acelyrin | 8-K: Current report

Dec 10 16:39 ET

Acelyrin | 4: Statement of changes in beneficial ownership of securities-Officer Murugan Amar

Nov 27 17:18 ET

Acelyrin | EFFECT: Others

Nov 25 06:27 ET

Acelyrin | 3: Initial statement of beneficial ownership of securities-Officer Murugan Amar

Nov 22 17:45 ET

Acelyrin | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. Rowe Price Investment Management, Inc.(10.5%)

Nov 14 13:36 ET

Acelyrin | S-3: Registration statement for specified transactions by certain issuers

Nov 13 17:27 ET

Acelyrin | 8-K: Current report

Nov 13 16:27 ET

Acelyrin | 10-Q: Q3 2024 Earnings Report

Nov 13 16:10 ET

Acelyrin | 8-K: ACELYRIN, INC. Reports Third Quarter 2024 Financial Results and Recent Highlights

Nov 13 16:09 ET

Acelyrin | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.07%)

Nov 12 12:17 ET

Acelyrin | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.0%)

Nov 8 14:30 ET

Acelyrin | 8-K/A: Current report (Amendment)

Nov 4 16:14 ET

Acelyrin | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(4.07%)

Nov 4 10:59 ET

Acelyrin | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.0%)

Oct 24 14:05 ET

Acelyrin | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. Rowe Price Investment Management, Inc.(10.5%)

Sep 10 13:53 ET

Acelyrin | 4: Statement of changes in beneficial ownership of securities-Officer Labrucherie Gil M

Sep 4 20:41 ET

Acelyrin | 10-Q: Q2 2024 Earnings Report

Aug 13 16:24 ET

Acelyrin | 8-K: ACELYRIN, INC. Announces Positive Phase 3 Data for Izokibep in Hidradenitis Suppurativa; Focuses Strategy on Lonigutamab and Reports Second Quarter 2024 Financial Results

Aug 13 16:18 ET

Acelyrin | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(3.922%),Abigail P. Johnson(3.922%)

Aug 12 09:45 ET

Acelyrin | 4: Statement of changes in beneficial ownership of securities-Director Becker Daniel J.

Jul 19 18:21 ET